Disclaimer PubMed and NLM
1.
Determinants of stress coping behaviors in patients with Multiple Sclerosis (MS-DSCB): development and psychometrics of a PRECEDE model-based questionnaire. Hosseini Z, Homayuni A, Ghanbarnejad A.
BMC Psychiatry. 2022 Aug 30;22(1):578. doi: 10.1186/s12888-022-04217-2.
PMID: 36042451
2.
Cellular Respiration in Thymic Fragments from Mice. Alshamsi M, Hassane M, Almarzooqi F, Souid AK.
Front Biosci (Landmark Ed). 2022 Jul 29;27(8):230. doi: 10.31083/j.fbl2708230.
PMID: 36042174
3.
Reliability and acceptance of dreaMS, a software application for people with multiple sclerosis: a feasibility study. Woelfle T, Pless S, Reyes O, Wiencierz A, Feinstein A, Calabrese P, Gugleta K, Kappos L, Lorscheider J, Naegelin Y.
J Neurol. 2022 Aug 30. doi: 10.1007/s00415-022-11306-5. Online ahead of print.
PMID: 36042020
4.
Toward Precision Phenotyping of Multiple Sclerosis. Pitt D, Lo CH, Gauthier SA, Hickman RA, Longbrake E, Airas LM, Mao-Draayer Y, Riley C, De Jager PL, Wesley S, Boster A, Topalli I, Bagnato F, Mansoor M, Stuve O, Kister I, Pelletier D, Stathopoulos P, Dutta R, Lincoln MR.
Neurol Neuroimmunol Neuroinflamm. 2022 Aug 30;9(6):e200025. doi: 10.1212/NXI.0000000000200025. Print 2022 Nov.
PMID: 36041861 Review.
5.
Mycoplasma Hominis: A Rare Case of Acute Otitis Media and Facial Nerve Paralysis. Sadhar B, Ko-Keeney E, Fornelli R, Lipman S.
Ear Nose Throat J. 2022 Aug 30:1455613221113814. doi: 10.1177/01455613221113814. Online ahead of print.
PMID: 36041826
6.
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials. Mexhitaj I, Lim N, Fernandez-Velasco JI, Zrzavy T, Harris KM, Muraro PA, Villar LM, Bar-Or A, Cooney LA.
J Immunol Methods. 2022 Aug 27:113344. doi: 10.1016/j.jim.2022.113344. Online ahead of print.
PMID: 36041516
7.
The Potential for Treg-Enhancing Therapies in Nervous System Pathologies. Olson KE, Mosley RL, Gendelman HE.
Clin Exp Immunol. 2022 Aug 30:uxac084. doi: 10.1093/cei/uxac084. Online ahead of print.
PMID: 36041453
8.
Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates. Covey TJ, Golan D, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Sergott R, Wilken J, Sima DM, Van Hecke W, Gudesblatt M.
Mult Scler Relat Disord. 2022 Aug 14;68:104116. doi: 10.1016/j.msard.2022.104116. Online ahead of print.
PMID: 36041331
9.
IL-33/ST2 axis in autoimmune disease. Shakerian L, Kolahdooz H, Garousi M, Keyvani V, Kamal Kheder R, Abdulsattar Faraj T, Yazdanpanah E, Esmaeili SA.
Cytokine. 2022 Aug 27;158:156015. doi: 10.1016/j.cyto.2022.156015. Online ahead of print.
PMID: 36041312 Review.
10.
D-mannose for preventing and treating urinary tract infections. Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G.
Cochrane Database Syst Rev. 2022 Aug 30;8:CD013608. doi: 10.1002/14651858.CD013608.pub2.
PMID: 36041061 Review.
11.
Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data. Maric G, Pekmezovic T, Mesaros S, Tamas O, Veselinovic N, Budimkic Stefanovic M, Jovanovic A, Drulovic J.
Neurol Sci. 2022 Aug 30. doi: 10.1007/s10072-022-06362-8. Online ahead of print.
PMID: 36040558
12.
Information-processing speed in mildly disabled relapsing-remitting multiple sclerosis patients correlates with volumetry of optic chiasma and subcortical grey matter nuclei. Kovacova S, Hnilicova P, Cierny D, Babalova L, Grossmann J, Kurca E, Kantorova E.
Bratisl Lek Listy. 2022;123(9):678-684. doi: 10.4149/BLL_2022_108.
PMID: 36039887
13.
Vagus nerve stimulation outcome prediction: from simple parameters to advanced models. Chrastina J, Novak Z, Zeman T, Dolezalova I, Zatloukalova E, Brazdil M.
Bratisl Lek Listy. 2022;123(9):641-647. doi: 10.4149/BLL_2022_103.
PMID: 36039882
14.
Psychosocial Impact of Multiple Sclerosis on Couples: Relationship Between Anxiety, Depression, and Stress Communication of Both Partners. Busch AK, Fringer A.
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221119142. doi: 10.1177/21501319221119142.
PMID: 36039811
15.
High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination. Zhai Y, Wang Q, Zhu Z, Hao Y, Han F, Hong J, Zheng W, Ma S, Yang L, Cheng G.
Biomater Sci. 2022 Aug 30. doi: 10.1039/d2bm00518b. Online ahead of print.
PMID: 36039673
16.
Sacral neuromodulation for neurological disease-induced lower urinary tract symptoms in Saudi Arabia: a single-centre experience. Banakhar MA.
J Int Med Res. 2022 Aug;50(8):3000605221117221. doi: 10.1177/03000605221117221.
PMID: 36039601
17.
Tuberous sclerosis complex with skin lesions as the initial presentation: A case report and multidisciplinary discussion. Deng S, Shi W, Cai Y, Tang Y, Liu W, Yin P, Chen C, Meng L, Dong H, Huang J, Liu Y.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jul 28;47(7):973-980. doi: 10.11817/j.issn.1672-7347.2022.210452.
PMID: 36039596 Chinese, English.
18.
Influence of eight weeks of combined training on adipsin and lipoprotein profile and possible relations with depression, anxiety and stress in women with multiple sclerosis. Cheragh Birjandi K, Sharafi J, Etemadizade A, Ghasemi E.
Horm Mol Biol Clin Investig. 2022 Aug 30. doi: 10.1515/hmbci-2022-0027. Online ahead of print.
PMID: 36039531
19.
Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles. Geiger M, Hayter E, Martin RS, Spence D.
J Transl Autoimmun. 2022 Aug 7;5:100161. doi: 10.1016/j.jtauto.2022.100161. eCollection 2022.
PMID: 36039310 Free PMC article. Review.
20.
More Than Meets the Eye: Isolated Bilateral Abducens Nerve Palsy as the Initial Presentation of Multiple Sclerosis. Ojemolon PE, Enejo RE, Evbayekha EO, Ituah LU, Shaka H.
Cureus. 2022 Jul 23;14(7):e27176. doi: 10.7759/cureus.27176. eCollection 2022 Jul.
PMID: 36039209 Free PMC article.
21.
Role of endoplasmic reticulum stress in impaired neonatal lung growth and bronchopulmonary dysplasia. Pritchard KA Jr, Jing X, Teng M, Wells C, Jia S, Afolayan AJ, Jarzembowski J, Day BW, Naylor S, Hessner MJ, Konduri GG, Teng RJ.
PLoS One. 2022 Aug 26;17(8):e0269564. doi: 10.1371/journal.pone.0269564. eCollection 2022.
PMID: 36018859 Free PMC article.
22.
Smarter adaptive platform clinical trials in neurology: a showcase for UK innovation. Mehta AR, Pal S, Chataway J, Carpenter JR, Parmar MKB, Chandran S.
Brain. 2022 Aug 27;145(8):e64-e65. doi: 10.1093/brain/awac169.
PMID: 35535817 No abstract available.
23.
Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease. Gabrielli M, Prada I, Joshi P, Falcicchia C, D’Arrigo G, Rutigliano G, Battocchio E, Zenatelli R, Tozzi F, Radeghieri A, Arancio O, Origlia N, Verderio C.
Brain. 2022 Aug 27;145(8):2849-2868. doi: 10.1093/brain/awac083.
PMID: 35254410 Free PMC article.
1.
Dietary Approaches to Treating Multiple Sclerosis-Related Symptoms. Wahls TL.
Phys Med Rehabil Clin N Am. 2022 Aug;33(3):605-620. doi: 10.1016/j.pmr.2022.04.004. Epub 2022 Jun 25.
PMID: 35989054 Review.
2.
Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with antagonist and agonist ligands. Goode-Romero G, Dominguez L.
J Mol Graph Model. 2022 Aug 7;117:108278. doi: 10.1016/j.jmgm.2022.108278. Online ahead of print.
PMID: 35988439
3.
Facial involvement in multiple sclerosis. Etemadifar M, Sabouri M, Zarepour M, Akhavan Sigari A, Salari M.
Mult Scler Relat Disord. 2022 Aug 13;67:104110. doi: 10.1016/j.msard.2022.104110. Online ahead of print.
PMID: 35988397
4.
Quantitative and qualitative features of acute phase-adverse events following SARS-CoV-2 vaccination in a large sample of people with multiple sclerosis. Tavazzi E, Della Porta G, Robustelli Della Cuna FS, Gervasio L, Guerra E, Tejada Condemayta MA, Filosa A, Montomoli C, Bergamaschi R.
Mult Scler Relat Disord. 2022 Aug 15;68:104120. doi: 10.1016/j.msard.2022.104120. Online ahead of print.
PMID: 35988330
5.
A systematic review with meta-analysis on balance, fatigue, and motor function following aquatic therapy in patients with multiple sclerosis. Shariat A, Ghayour Najafabadi M, Soroush Fard Z, Nakhostin-Ansari A, Shaw BS.
Mult Scler Relat Disord. 2022 Aug 13;68:104107. doi: 10.1016/j.msard.2022.104107. Online ahead of print.
PMID: 35988329 Review.
1.
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy. Moccia M, Affinito G, Berera G, Marrazzo G, Piscitelli R, Carotenuto A, Petracca M, Lanzillo R, Triassi M, Brescia Morra V, Palladino R.
J Neurol. 2022 Aug 11. doi: 10.1007/s00415-022-11320-7. Online ahead of print.
PMID: 35953597
2.
IVF and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk. Dobson R, Bove R.
Neurology. 2022 Aug 11:10.1212/WNL.0000000000201242. doi: 10.1212/WNL.0000000000201242. Online ahead of print.
PMID: 35953290 No abstract available.
3.
Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis. Mainguy M, Tillaut H, Degremont A, Le Page E, Mainguy C, Duros S, Polard E, Leray E.
Neurology. 2022 Aug 11:10.1212/WNL.0000000000201027. doi: 10.1212/WNL.0000000000201027. Online ahead of print.
PMID: 35953288
4.
Younger age at multiple sclerosis onset is associated with worse outcomes at age 50. Bose G, Healy BC, Barro C, Glanz BI, Lokhande HA, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T.
J Neurol Neurosurg Psychiatry. 2022 Aug 11:jnnp-2022-329353. doi: 10.1136/jnnp-2022-329353. Online ahead of print.
PMID: 35953266
5.
Oligoclonal bands: An immunological and clinical approach. Cabrera CM.
Adv Clin Chem. 2022;109:129-163. doi: 10.1016/bs.acc.2022.03.004. Epub 2022 Apr 22.
PMID: 35953125
6.
NLRP3 inflammasome in neurodegenerative disease. Anderson FL, Biggs KE, Rankin BE, Havrda MC.
Transl Res. 2022 Aug 8:S1931-5244(22)00179-7. doi: 10.1016/j.trsl.2022.08.006. Online ahead of print.
PMID: 35952982 Review.
7.
Epigenetic reader SP140 loss of function drives Crohn’s disease due to uncontrolled macrophage topoisomerases. Amatullah H, Fraschilla I, Digumarthi S, Huang J, Adiliaghdam F, Bonilla G, Wong LP, Rivard ME, Beauchamp C, Mercier V, Goyette P, Sadreyev RI, Anthony RM, Rioux JD, Jeffrey KL.
Cell. 2022 Aug 10:S0092-8674(22)00841-8. doi: 10.1016/j.cell.2022.06.048. Online ahead of print.
PMID: 35952671
8.
Physical frailty in patients with systemic sclerosis. Hax V, Tessari J, Pena E, Santo RCDE, Dos Santos LP, Gasparin AA, Bredemeier M, Fighera TM, Spritzer PM, Xavier RM, Chakr RMDS.
Semin Arthritis Rheum. 2022 Jul 28;56:152077. doi: 10.1016/j.semarthrit.2022.152077. Online ahead of print.
PMID: 35952534
9.
Myelin repair is fostered by the corticosteroid medrysone specifically acting on astroglial subpopulations. Silva Oliveira Junior M, Schira-Heinen J, Reiche L, Han S, de Amorim VCM, Lewen I, Gruchot J, Göttle P, Akkermann R, Azim K, Küry P.
EBioMedicine. 2022 Aug 8;83:104204. doi: 10.1016/j.ebiom.2022.104204. Online ahead of print.
PMID: 35952494
10.
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes. Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T.
Mult Scler Relat Disord. 2022 Jul 28;67:104079. doi: 10.1016/j.msard.2022.104079. Online ahead of print.
PMID: 35952457
11.
Correction to: Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease? Hadi Jazayeri M, Barzaman K, Nedaeinia R, Aghaie T, Motallebnezhad M.
Immunol Res. 2022 Aug 11. doi: 10.1007/s12026-022-09289-6. Online ahead of print.
PMID: 35951257 No abstract available.
12.
[Multiple sclerosis: interventions to halt disease : Which patients can be considered for autologous stem cell transplantation]. Willison AG, Meuth SG.
Nervenarzt. 2022 Aug 11. doi: 10.1007/s00115-022-01358-3. Online ahead of print.
PMID: 35951049 Review. German.
13.
CD20+ T cells: an emerging T cell subset in human pathology. Lee AYS.
Inflamm Res. 2022 Aug 11. doi: 10.1007/s00011-022-01622-x. Online ahead of print.
PMID: 35951029 Review.
14.
Optical Coherence Tomography Angiography in Chiasmitis. Cuna A, Pellegrini F, Interlandi E, Mandarà E, De Luca M, De Marco R, Ciabattoni C, Zappacosta A, Papayannis A.
Case Rep Ophthalmol. 2022 Jun 28;13(2):517-522. doi: 10.1159/000525465. eCollection 2022 May-Aug.
PMID: 35950028 Free PMC article.
15.
Non-invasive brain stimulation in rehabilitation. Kesikburun S.
Turk J Phys Med Rehabil. 2022 Mar 1;68(1):1-8. doi: 10.5606/tftrd.2022.10608. eCollection 2022 Mar.
PMID: 35949977 Free PMC article. Review.
16.
An uncommon case of primary biliary cirrhosis and Hashimoto thyroiditis followed by the concurrent onset of multiple sclerosis and Sjögren syndrome. Güzel Ş, Özen S.
Turk J Phys Med Rehabil. 2022 Mar 1;68(1):154-156. doi: 10.5606/tftrd.2022.6369. eCollection 2022 Mar.
PMID: 35949967 Free PMC article.
17.
Dapsone reduced cuprizone-induced demyelination via targeting Nrf2 and IKB in C57BL/6 mice. Dehpour AR, Khaledi E, Noori T, Mohammadi-Farani A, Delphi L, Sureda A, Sobarzo-Sanchez E, Shirooie S.
Iran J Basic Med Sci. 2022 Jun;25(6):675-682. doi: 10.22038/IJBMS.2022.64993.14310.
PMID: 35949308 Free PMC article.
18.
Cerebral Venous Thrombosis due to Cryptococcus in a Multiple Sclerosis Patient on Fingolimod. Kammeyer JA, Lehmann NM.
Case Rep Neurol. 2022 Jun 24;14(2):286-290. doi: 10.1159/000524359. eCollection 2022 May-Aug.
PMID: 35949205 Free PMC article.
19.
School performance and psychiatric comorbidity in juvenile absence epilepsy and juvenile myoclonic epilepsy: a Danish population-based cohort study. Boesen MS, Børresen ML, Christensen SK, Klein-Petersen AW, El Mahdaoui S, Sagar MV, Schou E, Eltvedt AK, Miranda MJ, Born AP, Uldall PV, Thygesen LC, Cacic Hribljan M.
J Neurol. 2022 Sep;269(9):4997-5007. doi: 10.1007/s00415-022-11147-2. Epub 2022 May 20.
PMID: 35595971
Nejnovější komentáře